Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences Inc. (NYSE: USNA) delivers science-backed nutritional supplements and personal care products through a global direct selling network. This page provides investors and industry observers with centralized access to official company announcements and market-moving developments.
Track USANA's latest press releases including quarterly financial results, product innovation announcements, executive leadership updates, and operational expansions. Our curated feed ensures timely access to filings, partnership disclosures, and strategic initiatives that shape the company's position in the health and wellness sector.
Key focus areas include regulatory milestones for nutritional products, market entry strategies in new regions, and advancements in manufacturing quality standards. All content is sourced directly from verified corporate communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of USANA's business trajectory, with updates organized chronologically for efficient research. Combine this resource with Stock Titan's financial analysis tools for comprehensive investment decision support.
USANA (NASDAQ:USNA) announced an extension of its partnership with the Jamaica Bobsleigh and Skeleton Federation through two additional Olympic cycles on Dec. 4, 2025. USANA will continue supplying nutritional products and will have its logo on the team's bobsled, helmets, and racing suits. The partnership began in early 2024; in November 2025 the Jamaica 4-man bobsled team won its first international gold at the North American Cup in Whistler, Canada. USANA said it will support the team as they prepare for future Olympic Games.
USANA (NYSE: USNA) marked National Make a Gift Day on Dec 3, 2025 with Executive Chairman Kevin Guest highlighting creative, non‑monetary gifts and the role of service in lasting relationships.
Guest, author of All the Right Reasons, shares personal courtship stories and links book sales to charity: each book sold funds 40 meals, and the book has provided more than 1.8 million meals through the USANA Foundation.
The release reiterates USANA's global reach in 25 countries and its focus on health, wellness, and social impact.
USANA (NYSE: USNA) announced that its MagneCal D supplement earned the ConsumerLab.com Seal of Approval on Nov 11, 2025, recognizing purity, potency, and label accuracy.
ConsumerLab testing required MagneCal D to deliver 100% of claimed amounts for magnesium, calcium, vitamin D, and boron, and to show proper disintegration and bioavailability. USANA highlighted the result as validation of its manufacturing, testing, and science-backed formulation. The product carries the standard supplement disclaimer that its statements have not been evaluated by the FDA.
USANA Foundation (NYSE:USNA) mobilized hundreds of volunteers on November 5, 2025, to pack 3,000 food bags for Utah children and families affected by recent federal SNAP cutbacks.
The event at USANA Foundation headquarters in West Valley City included partners such as Bountiful Food Pantry, For the Kids, the Utah Department of Cultural and Community Engagement, and Gathering for Impact. Bags will be distributed via five Salt Lake area school districts and partner pantries on November 6, 2025. Organizers said the effort provides short-term relief while urging ongoing donations at USANAFoundation.org.
USANA (NYSE: USNA) Executive Chairman Kevin Guest on Nov 3, 2025 urged CEOs to lead a "great re-engagement" through trust, empathy, and purpose rather than relying solely on perks or technology. He stressed values-driven leadership, holistic employee wellness (mental, physical, financial), and genuine relationships—what he calls "The Dorothy Principle." Guest cited scrapping a multimillion-dollar product batch to preserve quality and referenced his book All the Right Reasons as a guide for integrity-led management. He framed re-engagement as re-engaging our humanity to build durable culture and loyalty.
USANA (NYSE: USNA) reported fiscal Q3 2025 results for the period ended September 27, 2025: net sales $214M (+7% YoY) and a net loss of $6.5M (diluted EPS -$0.36). Adjusted diluted EPS was -$0.15 and Adjusted EBITDA was $13.8M (‑44% YoY). Direct selling Active Customers fell to 388,000 from 452,000. Hiya DTC delivered $31M sales and 193,400 active monthly subscribers, with 26% YTD sales growth.
The company ended Q3 with $145M cash, no debt, and ~$34M remaining share repurchase authority. Fiscal 2025 outlook was updated: consolidated net sales ~$920M, net earnings ~$15M, adjusted diluted EPS ~$1.73. Management cited a higher effective tax rate, investments for a new Brand Partner compensation plan, and a planned one-time $4.7M charge.
USANA (NYSE:USNA) updated the timing of its third quarter 2025 financial results release. The company will now issue its Q3 2025 earnings release after market close on Wednesday, October 22, 2025 instead of October 21. Shortly after the release, USANA will post its Management Commentary on its Investor Relations website under News/Events. USANA will host a conference call and live webcast for analysts and institutional investors on Thursday, October 23, 2025 at 11:00 a.m. Eastern Time.
Contact information for investor relations and links to the investor site and company websites were provided.
USANA (NYSE:USNA) announced on October 16, 2025 that its maximum-strength Vitamin D supplement earned the ConsumerLab.com Seal of Approval for potency, purity, and label accuracy.
The tablet delivers 50 mcg (2000 IU) vitamin D3 per dose and includes vitamin K; testing required 100% of claimed ingredient amounts plus proper disintegration and bioavailability. Company executives framed the certification as validation of USANA's manufacturing, third-party testing, and evidence-based product standards.
USANA (NYSE: USNA) reported preliminary Q3 2025 results: net sales $214 million versus $200 million a year ago. Operating earnings were approximately $1.2 million (0.6% of sales) versus $15.6 million in Q3 2024. Pretax earnings totaled $1.8 million but an $8.3 million income tax expense produced an unusually high 471% effective tax rate, driving a net loss of $6.5 million and diluted EPS of $(0.36). Adjusted diluted EPS was $(0.15) and Adjusted EBITDA was $13.8 million (vs. $24.6 million). Management cited softer Brand Partner productivity during a compensation-plan rollout and weaker Hiya DTC customer acquisition; Hiya is still expected to deliver double-digit sales growth in 2025. The company said full-year sales are likely at or near the low end of prior outlook and EPS will be below the prior range. Final results will be released Oct 21, 2025 and a call is scheduled Oct 22, 2025.
USANA (NYSE:USNA) announced that Chief Scientific Officer Dr. Kathryn Armstrong received the Women Tech Award — Leadership Excellence Award — from the Women Tech Council of Utah on Oct 6, 2025. The recognition highlights Dr. Armstrong's leadership in technology and scientific innovation and underscores USANA's emphasis on R&D, product quality, and support for women in the workplace. Dr. Armstrong leads a team of more than 150 scientific and quality professionals and joined USANA in 2024.
Her background includes a B.S. in Chemistry and a Ph.D. in Biochemistry; she credited the award to her USANA team and said it will motivate continued innovation.
FAQ
What is the current stock price of Usana Health Sciences (USNA)?
What is the market cap of Usana Health Sciences (USNA)?
